The author sold their position in Nebius ($NBIS), citing that the market had already priced in years of flawless execution despite looming competition. While maintaining a neutral long-term outlook on $NBIS, the author notes that "frenemies" like Meta ($META) and Microsoft ($MSFT) will inevitably compete with the company. Consequently, the author added two new unnamed positions to their portfolio following recent news regarding $META.